Slide Show: Colorectal Cancer Highlights From ASCO 2014

References:

1. Hong YS, Nam BH, Kim KP, et al. Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) for rectal cancer patients whose postoperative yp stage 2 or 3 after preoperative chemoradiotherapy: Updated results of 3-year disease-free survival from a randomized phase II study (The ADORE). Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting; Abstract 3502. Read More.

2. Venook AP, Niedzwiecki D, Lenz HJ, et al. CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC). Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting; Abstract LBA3. Read More.

3. Koopman M, Simkens L, May AM, et al. Final results and subgroup analyses of the phase 3 CAIRO3 study: Maintenance treatment with capecitabine + bevacizumab versus observation after induction treatment with chemotherapy + bevacizumab in metastatic colorectal cancer (mCRC). Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting; Abstract 3504. Read More.

4. Rodel C, Liersch T, Fietkau R, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: Results of the German CAO/ARO/AIO-04 randomized phase III trial. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting; Abstract 3500. Read More.

5. Schmoll HJ, Haustermans K, Price TJ, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting; Abstract 3531. Read More.

6. Shaik M, Tokala H, Modali R, et al. Effect of exercise and dietary fish consumption on risk of recurrence in colon cancer: A multinational study. Presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting; Abstract 1514.